Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,145,302Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1FRESENIUS KABI USA

02 10MAIA PHARMS INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

BORTEZOMIB

US Patent Number : 8962572

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205004

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-11-03

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

BORTEZOMIB

US Patent Number : 11752164

Drug Substance Claim :

Drug Product Claim :

Application Number : 215331

Patent Use Code : U-3632

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2042-09-23

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

BORTEZOMIB

US Patent Number : 11752164

Drug Substance Claim :

Drug Product Claim :

Application Number : 215331

Patent Use Code : U-3633

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2042-09-23

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

BORTEZOMIB

US Patent Number : 11752164

Drug Substance Claim :

Drug Product Claim :

Application Number : 215331

Patent Use Code : U-3632

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2042-09-23

blank

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

BORTEZOMIB

US Patent Number : 11752164

Drug Substance Claim :

Drug Product Claim :

Application Number : 215331

Patent Use Code : U-3633

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2042-09-23

blank

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

BORTEZOMIB

US Patent Number : 11679119

Drug Substance Claim :

Drug Product Claim :

Application Number : 215331

Patent Use Code : U-3632

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2042-09-23

blank

07

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

BORTEZOMIB

US Patent Number : 11679119

Drug Substance Claim :

Drug Product Claim :

Application Number : 215331

Patent Use Code : U-3633

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2042-09-23

blank

08

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

BORTEZOMIB

US Patent Number : 11679119

Drug Substance Claim :

Drug Product Claim :

Application Number : 215331

Patent Use Code : U-3632

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2042-09-23

blank

09

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

BORTEZOMIB

US Patent Number : 11679119

Drug Substance Claim :

Drug Product Claim :

Application Number : 215331

Patent Use Code : U-3633

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2042-09-23

blank

10

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

BORTEZOMIB

US Patent Number : 12005069

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 215331

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2042-09-23

blank